The New Paper

April 14, 2021

Johnson and Johnson suspends EU rollout of coronavirus vaccine

Johnson & Johnson delayed the rollout of its coronavirus vaccine in Europe and South Africa temporarily paused administration of the vaccine. The decisions came after US health officials recommended pausing use of the vaccine due to six reported cases of blood clotting (out of 6.8M doses administered). A CDC advisory panel will review the cases today.
This story is from the April 14, 2021 edition of The New Paper – a clear, concise daily briefing that makes fact-first news easy to consume. Try it today.